Computerized Cognitive and Skills Training in Older People with Mild Cognitive Impairment: Using Ecological Momentary Assessment to Index Treatment Related Changes in Real-World Performance of Technology-Dependent Functional Tasks
Metrics
Details
- Title
- Computerized Cognitive and Skills Training in Older People with Mild Cognitive Impairment: Using Ecological Momentary Assessment to Index Treatment Related Changes in Real-World Performance of Technology-Dependent Functional Tasks
- Creators
- Courtney Dowell-EsquivellSara J. CzajaPeter KallestrupColin A. DeppJohn N. SaberPhilip D. Harvey
- Publication Details
- The American journal of geriatric psychiatry
- Grant note
- Univer-sity of Miami Miller School of MedicinePI on the NIAMerck PharmaNovartis PharmaSunovion Pharma
This research was supported by NIA grants 1 R21 AG041740-01 (Czaja and Harvey) , and 1 R43 AG057238-04 (Kallestrup) , as well as by a grant from the Wallace Coulter Innovation Foundation. The intellectual propertyin the FUNSAT training system is licensed by the University of Miami Miller School of Medicine to i-Function, inc. Courtney Dowell-Equivel is a medical Student at the University of Miami Miller School of Medicine and reports no biomedical con fl icts of interest. Dr. Czaja is co-Chief Scienti fi c director and owns equity in i-Function. Mr. Kallestrup is CEO of iFunction, Inc, owns equity in i-Function, and was PI on the NIA grant supporting this study. Dr. Depp was compensated as a consultant to i-Function. Mr. Saber is a full-time employee of EMA Well-ness, who provided the EMA software. Dr. Harvey is co-CSI of i-Function and owns equity in i-Function. He has also served as a consultant to: Alkermes, Bioexcel, Boe-hinger-Ingelheim, Merck Pharma, Minerva Neurosciences, Karuna Therapeutics, Novartis Pharma, and Sunovion Pharma. He receives royalty payments for the Brief Assess-ment Cognition from WCG Endpoint Solutions (Formerly Neurocog Trials, Formerly Verasci) .r in the FUNSAT training system is licensed by the Univer-sity of Miami Miller School of Medicine to i-Function, inc. Courtney Dowell-Equivel is a medical Student at the Uni-versity of Miami Miller School of Medicine and reports no biomedical con fl icts of interest. Dr. Czaja is co-Chief Scien-ti fi c director and owns equity in i-Function. Mr. Kal-lestrup is CEO of iFunction, Inc, owns equity in i-Function, and was PI on the NIA grant supporting this study. Dr. Depp was compensated as a consultant to i-Function. Mr. Saber is a full-time employee of EMA Well-ness, who provided the EMA software. Dr. Harvey is co-CSI of i-Function and owns equity in i-Function. He has also served as a consultant to: Alkermes, Bioexcel, Boe-hinger-Ingelheim, Merck Pharma, Minerva Neurosciences, Karuna Therapeutics, Novartis Pharma, and Sunovion Pharma. He receives royalty payments for the Brief Assess-ment Cognition from WCG Endpoint Solutions (Formerly Neurocog Trials, Formerly Verasci) .
- Academic Unit
- Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
- Language
- English
- Resource Type
- Journal article
- PMID
- 37953132
- Record Identifier
- 991031948511902976